Psych CASC / OSCE · Child and adolescent psychiatry — early-onset psychosis
Explain early-onset psychosis care to parents — CASC communication station
MRCPsych/FRANZCP-style communication station: explain EOP pathway, organic/baseline checks, start-low antipsychotic with monitoring, family and school roles, cannabis advice, and clozapine threshold without fatalism.
On this page & tools
Target exams
Station brief
Format. Communication station, approximately 7–10 minutes active time after reading. You are the CAP psychiatry registrar in the youth early intervention / CAMHS clinic. [1]
Candidate instructions. Explain the working diagnosis of early-onset psychosis to the parents, outline medical checks and treatment (medication and psychosocial including school), discuss metabolic monitoring and cannabis, address what happens if the first medication does not work, and check understanding. The examiner plays both parents. [1]
Candidate scenario
Your patient, age 15, has a working diagnosis of early-onset psychosis after medical exclusion is underway. You plan to start a low-dose antipsychotic after baseline bloods and ECG.[1][2] He uses cannabis most weekends. Parents ask: "Is this schizophrenia forever? Will the drugs make him obese and diabetic? Should we pull him out of school permanently? What if the first tablet fails?" [1]
Marking domains
- Empathy, structure and agenda-setting
- Accurate plain-language explanation of EOP as a pathway (not day-one lifelong fatalism)
- Clear description of multi-element care including family and school
- Medication purpose, common side-effects (e.g. akathisia, metabolic risk) and monitoring
- Why early treatment matters (DUP)
- Cannabis counselling without blame
- Honest clozapine/threshold language if two adequate trials fail — without scaring them into non-engagement
- Checks understanding and safety-net [1][2][3][4]
Reveal assessor key
Open. Thank them; name the time; ask main worries first. [1]
Explain EOP. "Early-onset psychosis means a break from shared reality — for example fixed false beliefs and hearing a voice commenting — severe enough to affect school and relationships, starting before 18. Some young people recover substantially with early multi-element care; others need longer treatment. We avoid saying 'this is schizophrenia forever' on day one while still treating seriously." [1][4]
Explain care package. Medication reduces intensity of positive symptoms for many people; we start at a low dose and monitor closely. Weight, blood sugar and lipids matter because young people can gain metabolic risk early after antipsychotics — we measure from the start, not after a crisis.[2] We also offer family education, talking treatments, sleep and routine support, school liaison so education continues with adjustments, and help with cannabis. [1]
DUP. Longer time untreated links to poorer outcomes — seeking help now matters.[4]
If first tablet fails. We try an adequate trial (right dose, enough weeks, taking it as agreed). If two proper trials fail, a medicine called clozapine has the best evidence in hard-to-treat early-onset schizophrenia — it needs special blood monitoring, and we would discuss that carefully then, not as a day-one scare.[3]
School. May need temporary adjustment, not automatic permanent removal; recovery includes learning and roles. [1]
Close. Summarise, invite questions, crisis contacts, written info, review plan. [1]
References
- [1]McClellan J, Stock S, AACAP Committee on Quality Issues Practice parameter for the assessment and treatment of children and adolescents with schizophrenia J Am Acad Child Adolesc Psychiatry, 2013.PMID 23972700
- [2]Correll CU, et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents JAMA, 2009.PMID 19861668
- [3]Kumra S, et al. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison Biol Psychiatry, 2008.PMID 17651705
- [4]Marshall M, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review Arch Gen Psychiatry, 2005.PMID 16143729